Annual Current Liabilities
$36.76 M
-$26.03 M-41.46%
31 December 2023
Summary:
Taysha Gene Therapies annual total current liabilities is currently $36.76 million, with the most recent change of -$26.03 million (-41.46%) on 31 December 2023. During the last 3 years, it has fallen by -$14.99 million (-28.97%). TSHA annual current liabilities is now -41.46% below its all-time high of $62.79 million, reached on 31 December 2022.TSHA Current Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Current Liabilities
$29.34 M
-$4.84 M-14.16%
30 September 2024
Summary:
Taysha Gene Therapies quarterly total current liabilities is currently $29.34 million, with the most recent change of -$4.84 million (-14.16%) on 30 September 2024. Over the past year, it has dropped by -$7.42 million (-20.19%). TSHA quarterly current liabilities is now -83.74% below its all-time high of $180.45 million, reached on 30 September 2023.TSHA Quarterly Current Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TSHA Current Liabilities Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | - | -20.2% |
| 3 y3 years | -29.0% | -43.3% |
| 5 y5 years | +10000.0% | - |
TSHA Current Liabilities High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | -41.5% | +415.6% | -83.7% | at low |
| 5 y | 5 years | -41.5% | >+9999.0% | -83.7% | +311.5% |
| alltime | all time | -41.5% | >+9999.0% | -83.7% | +311.5% |
Taysha Gene Therapies Current Liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $29.34 M(-14.2%) |
| June 2024 | - | $34.18 M(-11.5%) |
| Mar 2024 | - | $38.64 M(+5.1%) |
| Dec 2023 | $36.76 M(-41.5%) | $36.76 M(-79.6%) |
| Sept 2023 | - | $180.45 M(+256.3%) |
| June 2023 | - | $50.64 M(-7.0%) |
| Mar 2023 | - | $54.45 M(-13.3%) |
| Dec 2022 | $62.79 M | $62.79 M(+89.5%) |
| Sept 2022 | - | $33.14 M(-22.8%) |
| June 2022 | - | $42.95 M(-11.7%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2022 | - | $48.62 M(-6.0%) |
| Dec 2021 | $51.75 M(+625.9%) | $51.75 M(+19.7%) |
| Sept 2021 | - | $43.21 M(+52.2%) |
| June 2021 | - | $28.39 M(+49.8%) |
| Mar 2021 | - | $18.96 M(+165.9%) |
| Dec 2020 | $7.13 M(+4652.7%) | - |
| Dec 2020 | - | $7.13 M(-38.7%) |
| Sept 2020 | - | $11.62 M(-42.1%) |
| June 2020 | - | $20.09 M |
| Dec 2019 | $150.00 K | - |
FAQ
- What is Taysha Gene Therapies annual total current liabilities?
- What is the all time high annual current liabilities for Taysha Gene Therapies?
- What is Taysha Gene Therapies quarterly total current liabilities?
- What is the all time high quarterly current liabilities for Taysha Gene Therapies?
- What is Taysha Gene Therapies quarterly current liabilities year-on-year change?
What is Taysha Gene Therapies annual total current liabilities?
The current annual current liabilities of TSHA is $36.76 M
What is the all time high annual current liabilities for Taysha Gene Therapies?
Taysha Gene Therapies all-time high annual total current liabilities is $62.79 M
What is Taysha Gene Therapies quarterly total current liabilities?
The current quarterly current liabilities of TSHA is $29.34 M
What is the all time high quarterly current liabilities for Taysha Gene Therapies?
Taysha Gene Therapies all-time high quarterly total current liabilities is $180.45 M
What is Taysha Gene Therapies quarterly current liabilities year-on-year change?
Over the past year, TSHA quarterly total current liabilities has changed by -$7.42 M (-20.19%)